Drug major Pfizer Inc. (PFE) announced Tuesday a definitive agreement to acquire Biohaven Pharmaceutical Holding Co. Ltd. (BHVN) for $148.50 per share in cash.In pre-market activity on NYSE, Biohaven shares were gaining around 71 percent to trade at $142.01.Biohaven is the maker of NURTEC ODT, an innovative dual-acting migraine therapy approved for both acute treatment and episodic prevention of m...
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.